Case 3:18-cv-02494-WQH-DEB Document 137 Filed 07/30/20 PageID.3198 Page 1 of 2


    1

    2

    3

    4

    5

    6

    7

    8                       UNITED STATES DISTRICT COURT
    9                     SOUTHERN DISTRICT OF CALIFORNIA
   10   MABVAX THERAPEUTICS                         Case No.: 3:18-cv-02494-WQH-MSB
   11   HOLDINGS, INC.,
                                       Plaintiff,
   12                                               ORDER

   13         v.

   14   SICHENZIA ROSS FERENCE LLP
   15   (F/K/A SICHENZIA ROSS FERENCE
        KESNER LLP; F/K/A SICHENZIA
   16   ROSS FRIEDMAN FERENCE LLP)
   17   AND HARVEY KESNER,
   18               Defendants.
   19   HAYES, Judge:
   20         WHEREAS, Plaintiff MabVax Therapeutics Holdings, Inc. (“MabVax”) and
   21   Defendants Sichenzia Ross Ference LLP (“SRF” or “Sichenzia”) and Harvey
   22   Kesner (“Kesner,” with SRF, “Defendants,” and with SRF and MabVax, the
   23   “Parties”) have filed a Joint Motion to Stay Pending Bankruptcy Court Approval of
   24   Settlement (ECF No. 136), and good cause being shown;
   25         IT IS HEREBY ORDERED THAT:
   26         1.    The action is stayed for a period of 120 days, pending action by the
   27   United States Bankruptcy Court for the District of Delaware regarding approval of
   28   the settlement contemplated by the Parties’ term sheet.

                                                    1


Case 3:18-cv-02494-WQH-DEB Document 137 Filed 07/30/20 PageID.3199 Page 2 of 2


    1         2.     If the Bankruptcy Court denies approval of the settlement, the Parties
    2   shall submit a status report to this Court within ten business days.
    3
        Dated: July 30, 2020
    4

    5

    6

    7

    8

    9
   10

   11

   12

   13

   14

   15

   16

   17

   18

   19
   20

   21

   22

   23

   24

   25

   26
   27

   28

                                                  2